Recruiting NCT04144439
Effect of GABA on ADHD and Seizures in Children With Epilepsy.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: GABA.
- Who it may be relevant to
- Registry conditions: Epilepsy. Basic parameters: 4 years — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effect of Gamma Aminobutyric Acid on ADHD and Seizures in Children With Epilepsy.
Overview
Effect of GABA on ADHD and seizures in Children with epilepsy.
Detailed description
Effect of Gamma aminobutyric acid on ADHD and seizures in Children with epilepsy.
Interventions
- Drug GABA
Gamma amino butyric acid
Primary outcome measures
- Number of seizures [Time frame: 6 months]
Eligibility criteria
Inclusion criteria
- Epilepsy
- ADHD
Exclusion criteria
- Epilepsy without ADHD
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Non-randomized
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Sherief Abd-Elsalam — Tanta
Identifiers
NCT: NCT04144439 · GABA